Abstract:Apart from their activity in combating infections, neutrophils play an important role in regulating the tumor microenvironment. Neutrophils can directly kill (antibody-coated) cancer cells, and support other immune anti-tumoral strategies. On the other hand, neutrophils can also exert pro-tumorigenic activities <i>via</i> the production of factors which promote cancer growth, angiogenesis and metastasis formation. The balance of anti- and pro-cancer activity is influenced by the particularly delicate interplay that exists between neutrophils and T lymphocytes. In murine models, it has been reported that γδ T cells are a major source of IL-17 that drives the recruitment and pro-tumorigenic differentiation of neutrophils. This, however, contrasts with the well-studied anti-tumor activity of γδ T cells in experimental models and the anti-tumor activity of human γδ T cells. In this article, we first review the reciprocal interactions between neutrophils, tumor cells and T lymphocytes with a special focus on their interplay with γδ T cells, followed by the presentation of our own recent results. We have previously shown that zoledronic acid (ZOL)-activated neutrophils inhibit γδ T-cell proliferation due to the production of reactive oxygen species, arginase-1 and serine proteases. We now demonstrate that killing of ductal pancreatic adenocarcinoma (PDAC) cells by freshly isolated resting human γδ T cells was reduced in the presence of neutrophils and even more pronounced so after activation of neutrophils with ZOL. In contrast, direct T-cell receptor-dependent activation by γδ T cell-specific pyrophosphate antigens or by bispecific antibodies enhanced the cytotoxic activity and cytokine/granzyme B production of resting human γδ T cells, thereby overriding the suppression by ZOL-activated neutrophils. Additionally, the coculture of purified neutrophils with autologous short-term expanded γδ T cells enhanced rather than inhibited γδ T-cell cytotoxicity against PDAC cells. Purified neutrophils alone also exerted a small but reproducible lysis of PDAC cells which was further enhanced in the presence of γδ T cells. The latter set-up was associated with improved granzyme B and IFN-γ release which was further increased in the presence of ZOL. Our present results demonstrate that the presence of neutrophils can enhance the killing capacity of activated γδ T cells. We discuss these results in the broader context of regulatory interactions between neutrophils and T lymphocytes.

Neutrophils with protumor potential could efficiently suppress tumor growth after cytokine priming and in presence of normal NK cells

Tumor-associated neutrophils suppress antitumor immunity of NK cells through the PD-L1/PD-1 axis

Tumor Induced PD-L1 on Neutrophils Suppress the Antitumor Immunity of NK Cells Via PD-L1/PD-1 Axis

Rational targeting of immunosuppressive neutrophils in cancer

Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures

Activated Mouse CD4+Foxp3- T Cells Facilitate Melanoma Metastasis Via Qa-1-dependent Suppression of NK Cell Cytotoxicity (127.17)

IL-6 cooperates with G-CSF to induce protumor function of neutrophils in bone marrow by enhancing STAT3 activation

Complete tumor resection reverses neutrophilia-associated suppression of systemic anti-tumor immunity

Regulatory Interactions Between Neutrophils, Tumor Cells and T Cells

Neutrophils Promote the Activation of Monocytes Via ROS to Boost Systemic Antitumor Immunity after Cryo-Thermal Therapy

Programming of the Development of Tumor-Promoting Neutrophils by Mesenchymal Stromal Cells

Neutrophils' dual role in cancer: from tumor progression to immunotherapeutic potential

Radiotherapy programs neutrophils to an antitumor phenotype by inducing mesenchymal-epithelial transition

A neutrophil response linked to tumor control in immunotherapy

Deterministic Reprogramming of Neutrophils Within Tumors.

Key role for neutrophils in radiation-induced antitumor immune responses: Potentiation with G-CSF

Tumor-Induced Suppression of Interferon-Gamma Production and Enhancement of Interleukin-10 Production by Natural Killer (nk) Cells: Paralleled to Cd4(+) T Cells

Neutrophils in the tumor microenvironment: role in tumor progression and potential targeted therapeutic strategy

A subset of neutrophils activates anti-tumor immunity and inhibits non-small-cell lung cancer progression

Improved Antitumor Effect of NK Cells Activated by Neutrophils in a Bone Marrow Transplant Model

Harnessing NK cell-based immunotherapy to prevent the high-dose radiotherapy-inducing tumor survival recurrence